Skip to main content
. 2009 May;2(3):135–141. doi: 10.1177/1756285609102769

Table 1.

Demographics (efficacy population).

  Sumatriptan/naproxen sodium (n = 726) Sumatriptan (n = 723) Naproxen sodium (n = 720) Placebo (n = 742)
Female, n (%) 633 (87) 625 (86) 630 (88) 644 (87)
White, n (%) 650 (90) 635 (88) 647 (90) 656 (88)
Median age, years (range) 40 (18-65) 40 (18-65) 40 (18-65) 41 (18-65)